DavidPenberthyMDMBA(He/Him)

Radiation Oncology • Charlottesville, VA

Associate Professor of Radiation Oncology

Join to view full profile

Dr. Penberthy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Penberthy's full profile

Already have an account?

Office
1240 Lee St
Charlottesville, VA 22908
Phone+1 434-924-9333

Education & Training

University of Virginia MBA, Business, 2009 - 2011
University of Virginia Medical CenterResidency, Radiation Oncology, 1998 - 2002
National Capital ConsortiumInternship, Transitional Year, 1994 - 1995
Virginia Commonwealth University School of MedicineClass of 1994

Certifications & Licensure

TN State Medical License 2022 - 2027
NC State Medical License 2022 - 2026
VA State Medical License 1995 - 2026
PA State Medical License 2021 - 2024
WV State Medical License 2001 - 2015
GA State Medical License 2006 - 2009
American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

4 citations
Psychological Aspects of Breast Cancer.
Jennifer Kim Penberthy, Anne Louise Stewart, Caroline F Centeno, David R Penberthy
The Psychiatric Clinics of North America. 2023-09-01
5 citations
Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
Kimberly S. Keene, Tyvin A. Rich, David R. Penberthy, Robert C. Shepard, Reid B. Adams
International Journal of Radiation Oncology, Biology, Physics. 2005-05-01
5 citations
Postoperative adjuvant therapy for pancreatic cancer.
David R. Penberthy, Tyvin A. Rich, Reid B. Adams
Seminars in Surgical Oncology. 2003-11-01

Press Mentions

Transforming Cancer Care Delivery and Patient Experiences Through Technology with David Penberthy, MD, MBAJune 28th, 2022
Ibrutinib Extends Survival for Older Mantle Cell Lymphoma PatientsJune 8th, 2022
Rucaparib Is Effective in Maintenance Treatment for Ovarian CancerJune 8th, 2022
Join now to see all